Want to join the conversation?
David Risinger with Morgan Stanley asks about OTC Nexium, how competitive the company expects that market to be within a year of launch. $PRGO said that it's hard to know how many competitors are out there. It's not the easiest product to make, sell, distribute and manufacture. There might be a few approvals in the market similar to omeprazole.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.